Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 9789089 Therapeutic compounds

Patent 9789089 was granted and assigned to Gilead Sciences on October, 2017 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent attributes

Patent Applicant

Gilead Sciences

Current Assignee

Gilead Sciences

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

Patent Inventor Names

Chien-Hung Chou0

Carina E. Cannizzaro0

Jennifer R. Zhang0

John O. Link0

Qi Liu0

Scott D. Schroeder0

Steven S. Bondy0

Winston C. Tse0

Date of Patent

October 17, 2017

Patent Application Number

14943931

Date Filed

November 17, 2015

Patent Citations Received

US Patent 11944611 Capsid inhibitors for the treatment of HIV

0

US Patent 11993583 Therapeutic compounds

0

US Patent 12084467 Therapeutic compounds for HIV virus infection

0

US Patent 11685728 Capsid inhibitors for the prevention of HIV

0

US Patent 11680064 Capsid inhibitors for the treatment of HIV

0

US Patent 11753399 Therapeutic compounds

US Patent 11760746 Methods and intermediates for preparing therapeutic compounds

US Patent 11833143 Choline salt forms of an HIV capsid inhibitor

0

...

Patent Primary Examiner

Shawquia Jackson

Patent abstract

Compounds of formula I:

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 9789089 Therapeutic compounds

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool